Investor Alert

New York Markets Close in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Feb 1, 2023, 11:00 a.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.86

Change

-0.04 -2.11%

Volume

Volume 3,756

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.90

$ 1.86

Change

-0.04 -2.11%

Day low

Day high

$1.84

$1.89

Open

52 week low

52 week high

$0.88

$3.45

Open

Adele M. Gulfo

Currently, Adele M. Gulfo is Board of Advisor at 1843 Capital LLC. Ms. Gulfo is also on the board of EnPro Industries, Inc., Medexus Pharmaceuticals, Inc. and Myovant Sciences Ltd. and Chief Business & Commercial Development Officer at Sumitovant Biopharma, Inc.

Adele M. Gulfo previously occupied the position of President-Latin America Region at Pfizer Inc., Chairman-Commercial Development at Roivant Sciences Ltd., EVP-Global Collaboration & Strategic Operations at Mylan, Inc. and EVP & Head of Global Commercial Development at Mylan NV.

Adele M. Gulfo received an undergraduate degree from Seton Hall University, an MBA from Fairleigh Dickinson University and a graduate degree from the University of Medicine & Dentistry of New Jersey.

Transactions

Date Shares Transaction Value
12/20/2022 1,168   0
09/16/2022 10,052   0
06/27/2022 1,921   0
01/20/2022 5,135   0
01/20/2022 5,135   0
01/20/2022 5,135   0
01/20/2022 5,135   0
01/10/2022 5,135   0
12/24/2021 1,149   0
10/01/2021 4,396   13,231
09/23/2021 4,012   0
07/01/2021 1,966   13,997
06/28/2021 1,723   0
04/01/2021 1,958   0
12/19/2020 1,071   0
06/25/2020 1,819   0
06/25/2020 2,150   0
06/25/2020 2,150   0
06/25/2019 0   0

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.